Halozyme Therapeutics Inc (HALO)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt HALO? Forum Prognose

Finanzdaten der Halozyme Therapeutics Inc-Aktie (HALO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	22.98% 325.72	264.86	298.01	290.08	231.35
Cost Of Revenue	4.22% 46.36	48.40	42.05	49.43	39.61
Gross Profit	29.06% 279.36	216.46	255.95	240.66	191.75
Operating Expenses	2.66% 76.92	74.92	80.45	77.46	74.51
Benefits Costs and Expenses	0.21% 120.78	121.03	119.79	124.94	113.61
Costs And Expenses	0.04% 123.28	123.33	122.51	126.89	114.12
Operating Income/Loss	43.03% 202.44	141.53	175.50	163.20	117.23
Income/Loss From Continuing Operations Before Tax	42.49% 204.94	143.83	178.21	165.15	117.74
Income Tax Expense/Benefit	54.58% 39.78	25.73	41.20	28.14	24.50
Income/Loss From Continuing Operations After Tax	39.85% 165.16	118.09	137.01	137.01	93.25
Net Income/Loss	39.85% 165.16	118.09	137.01	137.01	93.25
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.52% 121.34	123.22	-0.142	126.85	127.12
Diluted Average Shares	1.96% 124.16	126.64	-0.102	130.13	129.22
Basic Earnings Per Share	41.67% 1.36	0.96	1.08	1.08	0.73
Diluted Earnings Per Share	43.01% 1.33	0.93	1.06	1.05	0.72
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$85.44

1.75%

GMAB

$27.38

1.11%

SMMT

$23.80

1.19%

BNTX

$103.50

3.07%

INSM

$142.53

0.68%

ONC

$318.73

5.21%